Charles River Laboratories International, Inc. (CRL): Price and Financial Metrics


Charles River Laboratories International, Inc. (CRL)

Today's Latest Price: $161.05 USD

1.41 (-0.87%)

Updated Feb 26 4:10pm

Add CRL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

CRL Stock Summary

  • With a market capitalization of $7,757,574,847, Charles River Laboratories International Inc has a greater market value than 81.19% of US stocks.
  • With a price/earnings ratio of 33.53, Charles River Laboratories International Inc P/E ratio is greater than that of about 74.56% of stocks in our set with positive earnings.
  • Revenue growth over the past 12 months for Charles River Laboratories International Inc comes in at 18.13%, a number that bests 74.84% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Charles River Laboratories International Inc are LEG, OGS, CHH, UBSI, and TMP.
  • CRL's SEC filings can be seen here. And to visit Charles River Laboratories International Inc's official web site, go to www.criver.com.
CRL Daily Price Range
CRL 52-Week Price Range

CRL Stock Price Chart More Charts


CRL Price/Volume Stats

Current price $161.05 52-week high $179.38
Prev. close $162.46 52-week low $123.17
Day low $159.88 Volume 412,933
Day high $164.86 Avg. volume 371,203
50-day MA $158.48 Dividend yield N/A
200-day MA $140.14 Market Cap 7.89B

Charles River Laboratories International, Inc. (CRL) Company Bio


Charles River Laboratories provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company was founded in 1947 and is based in Wilmington, Massachusetts.

CRL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$161.05$110.28 -34%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Charles River Laboratories International Inc. To summarize, we found that Charles River Laboratories International Inc ranked in the 42st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Charles River Laboratories International Inc, consider:

  • Charles River Laboratories International Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 5.96. This coverage rate is greater than that of 59.75% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • The weighted average cost of capital for the company is 8. This value is greater than merely 15.27% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-35%
1%-35%
2%-34%
3%-34%
4%-33%
5%-32%

Want more companies with a valuation profile/forecast similar to that of Charles River Laboratories International Inc? See ENTA, NVST, TARO, HBIO, and STE.


CRL Latest News Stream


Event/Time News Detail
Loading, please wait...

CRL Latest Social Stream


Loading social stream, please wait...

View Full CRL Social Stream

CRL Price Returns

1-mo 4.19%
3-mo 9.65%
6-mo 22.75%
1-year 14.46%
3-year 82.91%
5-year 110.06%
YTD 5.43%
2019 34.97%
2018 3.41%
2017 43.65%
2016 -5.22%
2015 26.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6645 seconds.